Filter
1245
Text search:
Vaccine
production
Featured
Recommendations
134
New Publications
322
Language
Document type
No document type
580
Studies & Reports
263
Guidelines
161
Strategic & Response Plan
91
Manuals
63
Fact sheets
40
Training Material
15
Situation Updates
15
Resource Platforms
6
Infographics
4
Brochures
3
Online Courses
2
App
1
Videos
1
Countries / Regions
Global
81
Nigeria
43
India
37
Kenya
36
Sierra Leone
32
Latin America and the Carribbean
27
Ethiopia
26
Africa
26
Liberia
25
Tanzania
24
South Africa
23
Uganda
20
Ghana
19
Nepal
18
Congo, Democratic Republic of
15
Western and Central Europe
15
Zambia
14
Bangladesh
14
Malawi
13
Philippines
12
Syria
12
Rwanda
12
Zimbabwe
11
Pakistan
11
Lesotho
11
West and Central Africa
11
Haiti
10
Ukraine
10
Myanmar / Burma
10
Mozambique
9
South–East Asia Region
9
East and Southern Africa
8
Middle East and North Africa
8
Senegal
7
South Sudan
7
Sudan
7
Namibia
7
Guinea
6
Brazil
6
Afghanistan
5
Germany
5
Cambodia
5
Indonesia
5
Botswana
5
USA
4
Eswatini/ Swaziland
4
Eastern Europe
4
Mali
3
Iraq
3
Jordan
3
Lebanon
3
Thailand
3
Benin
3
Madagascar
3
Yemen
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Laos
3
United Kingdom
3
Burkina Faso
2
Saudi Arabia
2
Cameroon
2
Togo
2
Turkey
2
Egypt
2
Papua New Guinea
2
Libya
2
Sri Lanka
2
Paraguay
2
Timor Leste/ East Timor
2
Vietnam
2
Somalia
1
Chad
1
China
1
Central African Republic
1
Argentina
1
Peru
1
North Macedonia
1
Burundi
1
Colombia
1
Bolivia
1
Chile
1
Other region
1
Palestine
1
Djibouti
1
Tajikistan
1
Russia
1
Qatar
1
Moldova
1
Iran
1
Georgia
1
Turkmenistan
1
France
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
476
Clinical Guidelines
133
Public Health
73
Women & Child Health
50
Key Resources
47
Pharmacy & Technologies
21
Capacity Building
8
Toolboxes
COVID-19
217
Rapid Response
77
AMR
60
TB
58
NTDs
44
Ebola
43
HIV
42
Planetary Health
41
Health Financing Toolbox
32
Conflict
29
Global Health Education
29
Pharmacy
25
Polio
21
Cholera
20
Natural Hazards
16
Caregiver
13
Refugee
12
Mental Health
9
NCDs
8
Disability
7
Specific Hazards
6
Zika
4
South Sudan
1
Health Financing
1
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health
...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass
...
The objective of Critical Considerations and Actions for Achieving Universal Access to Sexual and Reproductive Health in the Context of Universal Health Coverage through a Primary Health Care Approach is to provide guidance to WHO Member States for ensuring progress towards universal access to compr
...
CATALYST DIALOGUE ON HEALTH FINANCING
Insights from a debate on how to increase funding for health and spend existing funds more effectively.
Catalyst Dialogue participants:
Christoph Benn, Director for Global Health Diplomacy, Joep Lange Institute • Jayati Ghosh, Professor of Economics, Univer
...
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting,
...
The present information document supplements the WHO audited financial statements for 2018. It contains information on WHO's voluntary contributions by fund and by contributor in the year 2018.
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively.
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in
...
Cholera remains a significant public health threat in many countries worldwide. In resource-constrained settings, it disproportionately affects thousands of poor and vulnerable population
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current
...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p
...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy
...
